Biotech Denali Therapeutics Tops 3 IPOs Totaling $506M
Shares of Denali Therapeutics Inc. soared Friday after the company raised $250 million in an upsized initial public offering that amounted to the largest biotechnology IPO of 2017, leading one of...To view the full article, register now.
Already a subscriber? Click here to view full article